Her research focuses on large-scale brain network organization, with particular emphasis on functional brain gradient alterations across psychiatric disorders. Through this work, she aims to improve the understanding of disease mechanisms to inform the development of more targeted and better-tolerated treatment approaches. In addition, she investigates pharmacological strategies for managing treatment-resistant schizophrenia, focusing on clinical decision-making and the handling of severe side effects. A key goal of her work is to translate neurobiological insights into practical therapeutic options for complex clinical cases.